4
Changes in Ownership
Cocrystal Pharma, Inc. Filed Acc 0001493152-17-014433
Options or other derivatives
- Director acquired 1,851,851 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Schinazi Raymond F Director | 2017-11-24 | Grant or award · 8% Convertible Note | +1,851,851 | $500,000.00 | $925,925,500,000 | 1,851,851 | I |
Loading xslF345X03/form4.xml…